Revolution Medicines, Inc. (RVMD) stock
RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30
$159.82−2.87 (-1.76%)
Close on Nov 18, 2026Market cap $34.26BP/E –Yield –
Revolution Medicines price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Revolution Medicines's price to sales ratio was 458.3× on Mar 28, 2024, against 55.4× a year earlier. Over the last 4 years it ranged from 1.4× to 458.3×, with a median of 56.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Mar 28, 2024 | 458.3× | +338.4 |
| 2023 | Dec 29, 2023 | 120.0× | +49.1 |
| 2022 | Dec 30, 2022 | 70.9× | +6.2 |
| 2021 | Dec 31, 2021 | 64.6× | +8.0 |
| 2020 | Dec 31, 2020 | 56.7× | – |
See a number that looks wrong?